샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793718

세계의 의사 진료실 진단 시장

Physician Office Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 299 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의사 진료실 진단 세계 시장은 2030년까지 2억 3,650만 달러에 달할 전망

2024년에 1억 1,590만 달러로 추정되는 의사 진료실 진단 세계 시장은 2030년에는 2억 3,650만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 12.6%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 Point-of-Care 검사 기기는 CAGR 14.6%를 기록하며 분석 기간 종료시에는 1억 1,410만 달러에 달할 것으로 예측됩니다. 임상화학 분석기 부문의 성장률은 분석 기간 동안 CAGR 10.1%로 추정됩니다.

미국 시장은 추정 3,160만 달러, 중국은 CAGR 17.3%로 성장 예측

미국의 의사 진료실 진단 시장은 2024년에는 3,160만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간 2024년부터 2030년까지 CAGR 17.3%로 성장하여 2030년에는 예측 시장 규모 5,060만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 9.0%와 11.4%로 예측됩니다. 유럽에서는 독일이 CAGR 10.0%로 성장할 것으로 예측됩니다.

세계의 의사 진료실 진단 시장 - 주요 동향과 촉진요인 정리

왜 의료기관과 환자들 사이에서 내원 진단이 선호되는 이유는 무엇일까?

의사 진료실 진단은 정기적인 진료 시 시행되는 다양한 검사를 포괄하여 적시에 진단 및 치료 결정을 내릴 수 있도록 도와줍니다. 혈액검사, 소변검사, 심전도, 영상 진단, 신속항원검사, 현장진단분석기 등이 포함됩니다. 현장 진단의 편의성은 임상 효율성, 환자 순응도, 진단 소요 시간을 향상시킵니다.

당뇨병, 호흡기 감염, 심혈관질환, 성병 등의 진단 도구에 투자하는 의사들도 늘고 있습니다. 이러한 도구는 일차 진료 및 응급 의료 현장에서 특히 중요한 외부 검사실 방문 및 후속 진료 예약의 필요성을 줄이는 데 도움이 됩니다. 즉각적인 결과 제공은 환자의 만족도를 높이고, 즉시 치료를 시작할 수 있게 해줍니다.

일차의료 현장을 지원하는 진단 기술은 어떻게 진화하고 있을까?

최신 의사 진료실 진단은 최소한의 샘플 조제로 정확한 결과를 제공하는 컴팩트하고 사용하기 쉬운 기기에 초점을 맞추고 있습니다. 현재 POC 검사 플랫폼에는 면역 측정법, 분자진단법, 소규모 진료소를 위해 설계된 디지털 영상 진단 도구가 포함되어 있습니다. 무선 연결이 가능한 자동 분석기는 워크플로우를 간소화하고 문서화 표준을 준수하기 위해 채택되었습니다.

웨어러블 진단기기와 휴대용 초음파 진단기기도 일차 진료에 도입되어 검사 능력의 확대가 가능해졌습니다. 클라우드에 연결된 진단 플랫폼은 전자 의료 기록(EHR)과의 데이터 통합을 용이하게 하고, 진료의 연속성과 집단 건강 추적을 향상시킵니다. 측면 흐름 기술, 미세유체 공학, 멀티플렉스 검사의 발전으로 진단 속도와 정확도가 더욱 향상되고 있습니다.

채용이 확대되는 곳은 어디이며, 어떤 검사 카테고리가 가장 활발한가?

의사 진료실 진단은 가정 의료, 내과, 소아과, 응급 의료에서 널리 사용됩니다. 특히 만성질환 관리, 감염 감지, 심혈관 위험 모니터링을 지원하는 검사에 대한 수요가 높습니다. 여기에는 HbA1c, 지질 패널, 연쇄상구균 검사, 독감 및 COVID-19 검사, 소변 검사, 심전도 등이 포함됩니다.

북미는 일차의료의 높은 수준의 인프라와 상환 지원으로 인해 여전히 가장 큰 시장으로 남아 있습니다. 그러나 일차의료제도가 확대되고 있는 유럽과 아시아태평양에서도 도입이 진행되고 있습니다. 예방 검진 및 만성질환 관리를 개선하기 위한 정부의 노력도 사무실 기반 진료 환경에서의 진단 접근을 촉진하고 있습니다.

의사 진료실 진단 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다.

의사 진료실 진단 시장의 성장 원동력은 진료 현장에서의 신속한 진단 검사에 대한 수요 증가, 만성질환의 유병률 증가, 소형화 된 POC(Point-of-Care) 기술의 발전입니다. 자동분석기 보급, 전자 의료 시스템과의 통합, 질환별 신속 검사 확대 등이 보급을 촉진하고 있습니다.

또한, 의사들은 진료 효율성을 높이고, 환자 대기 시간을 단축하고, 진료 연계를 개선하기 위해 진단에 투자하고 있습니다. 예방적 검진 및 만성질환 모니터링을 지원하는 진료비 보상 체계는 시장의 안정성을 강화하고 있습니다. 환자 수가 증가하고 즉각적인 진료에 대한 기대가 높아짐에 따라, 도시와 지방의 진료 환경 전반에 걸쳐 진료실 내 진단약에 대한 수요는 계속 증가할 것으로 보입니다.

부문

제품 유형(POC(Point of Care) 검사 기기, 임상화학 분석기, 면역측정 시스템, 분자진단 장비, 소변 검사 시스템), 용도(감염증 용도, 심혈관질환 용도, 대사질환 용도, 암 진단 용도, 임신 용도, 불임 검사 용도)

조사 대상 기업 사례

  • Abbott Laboratories
  • Alere Inc.(Now Abbott)
  • BD(Becton, Dickinson and Co.)
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Cepheid
  • EKF Diagnostics
  • F. Hoffmann-La Roche Ltd
  • HemoCue AB
  • HORIBA Medical
  • Labcorp
  • Nova Biomedical
  • Ortho Clinical Diagnostics
  • QuidelOrtho Corporation
  • Radiometer Medical
  • Randox Laboratories
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.26

Global Physician Office Diagnostics Market to Reach US$236.5 Million by 2030

The global market for Physician Office Diagnostics estimated at US$115.9 Million in the year 2024, is expected to reach US$236.5 Million by 2030, growing at a CAGR of 12.6% over the analysis period 2024-2030. Point-of-Care Testing Devices, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$114.1 Million by the end of the analysis period. Growth in the Clinical Chemistry Analyzers segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.6 Million While China is Forecast to Grow at 17.3% CAGR

The Physician Office Diagnostics market in the U.S. is estimated at US$31.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$50.6 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 11.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.0% CAGR.

Global Physician Office Diagnostics Market - Key Trends & Drivers Summarized

Why Are In-Office Diagnostics Gaining Preference Among Providers and Patients?

Physician office diagnostics encompass a wide range of tests conducted during a routine visit, allowing timely diagnosis and treatment decisions. These include blood tests, urinalysis, ECGs, imaging, rapid antigen tests, and point-of-care analyzers. The convenience of conducting diagnostics on-site improves clinical efficiency, patient compliance, and diagnostic turnaround times.

Physicians are increasingly investing in diagnostic tools for conditions such as diabetes, respiratory infections, cardiovascular disease, and sexually transmitted infections. These tools help reduce the need for external lab visits and follow-up appointments, particularly important in primary care and urgent care settings. The ability to deliver immediate results enhances patient satisfaction and enables same-day treatment initiation.

How Are Diagnostic Technologies Evolving to Support Primary Care Settings?

Modern physician office diagnostics focus on compact, user-friendly devices that offer accurate results with minimal sample preparation. Point-of-care testing platforms now include immunoassays, molecular diagnostics, and digital imaging tools designed for small practice environments. Automated analyzers with wireless connectivity are being adopted to streamline workflow and ensure compliance with documentation standards.

Wearable diagnostics and portable ultrasound devices are also entering primary care practices, enabling expanded examination capabilities. Cloud-connected diagnostic platforms facilitate data integration with electronic health records (EHRs), improving continuity of care and population health tracking. Advances in lateral flow technology, microfluidics, and multiplex testing are further enhancing diagnostic speed and precision.

Where Is Adoption Expanding and Which Test Categories Are Most Active?

Physician office diagnostics are widely used across family medicine, internal medicine, pediatrics, and urgent care. Demand is particularly high for tests that support chronic disease management, infectious disease detection, and cardiovascular risk monitoring. These include HbA1c, lipid panels, strep tests, flu and COVID-19 testing, urinalysis, and ECGs.

North America remains the largest market due to advanced primary care infrastructure and reimbursement support. However, adoption is growing in Europe and Asia-Pacific, where primary care systems are expanding. Government initiatives to improve preventive screening and chronic disease management are also promoting diagnostic access in office-based care environments.

Growth in the Physician Office Diagnostics market is driven by several factors…

Growth in the physician office diagnostics market is driven by the rising demand for rapid, in-practice diagnostic testing, increasing prevalence of chronic diseases, and advances in compact, point-of-care technologies. Broader use of automated analyzers, integration with electronic health systems, and expansion of disease-specific rapid tests are supporting adoption.

Physicians are also investing in diagnostics to enhance practice efficiency, reduce patient wait times, and improve care coordination. Reimbursement frameworks that support preventive screenings and chronic condition monitoring are strengthening market stability. As patient volume grows and expectations for immediate care rise, demand for in-office diagnostics is set to continue increasing across urban and rural care settings.

SCOPE OF STUDY:

The report analyzes the Physician Office Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, Urinalysis Systems); Application (Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application, Cancer Diagnosis Application, Pregnancy Application, Fertility Testing Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • Alere Inc. (Now Abbott)
  • BD (Becton, Dickinson and Co.)
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Cepheid
  • EKF Diagnostics
  • F. Hoffmann-La Roche Ltd
  • HemoCue AB
  • HORIBA Medical
  • Labcorp
  • Nova Biomedical
  • Ortho Clinical Diagnostics
  • QuidelOrtho Corporation
  • Radiometer Medical
  • Randox Laboratories
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Physician Office Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Rapid and On-the-Spot Test Results Propels Growth in Physician Office Diagnostics
    • Shift Toward Decentralized Healthcare Delivery Expands the Role of In-Office Diagnostic Testing
    • Point-of-Care Technology Advancements Strengthen the Business Case for Diagnostic Equipment in Primary Care
    • Increasing Chronic Disease Burden Fuels Demand for Routine Testing and Real-Time Monitoring in Clinics
    • Patient Preference for Convenience and Faster Diagnosis Drives Adoption of In-Office Testing Solutions
    • Integration with Electronic Health Records (EHR) Enhances Workflow Efficiency and Diagnostic Accuracy
    • Growth in Preventive and Personalized Medicine Supports Expansion of Multi-Panel Diagnostic Tools
    • Cost Pressures and Value-Based Care Models Propel Use of In-House Diagnostics to Reduce Referrals and Delays
    • Miniaturization and Connectivity in Diagnostic Devices Enable Broader Use in Smaller Physician Practices
    • Expansion of Diagnostic Capabilities in Family and Internal Medicine Clinics Sustains Market Growth
    • Training and Ease-of-Use Improvements Drive Wider Adoption Among Non-Specialist Healthcare Providers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Physician Office Diagnostics Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Physician Office Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Point-of-Care Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Point-of-Care Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Point-of-Care Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Clinical Chemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Clinical Chemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Clinical Chemistry Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Urinalysis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Urinalysis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Urinalysis Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pregnancy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pregnancy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pregnancy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fertility Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fertility Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Fertility Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Cardiovascular Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Cardiovascular Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Cardiovascular Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Metabolic Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Metabolic Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Metabolic Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Cancer Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Cancer Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Cancer Diagnosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • CHINA
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Physician Office Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: France 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Physician Office Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • INDIA
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 128: India Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: India 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 131: India Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: India 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Physician Office Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Physician Office Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제